Cargando…

A Novel Approach to Extensive Clarithromycin- Resistant Mycobacterium avium Complex Pulmonary Disease

A 48-year-old woman with extensive clarithromycin-resistant Mycobacterium avium complex pulmonary disease (MAC-PD) was successfully treated by left lower lobectomy and lingulectomy following combination treatment of intravenous/inhaled amikacin plus bronchial occlusion by Endobronchial Watanabe Spig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Togo, Takeo, Atsumi, Jun, Hiramatsu, Miyako, Shimoda, Kiyomi, Morimoto, Kozo, Shiraishi, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763718/ https://www.ncbi.nlm.nih.gov/pubmed/33967121 http://dx.doi.org/10.5761/atcs.cr.21-00010

Ejemplares similares

Proteomic Profiling Reveals the Architecture of Granulomatous Lesions Caused by Tuberculosis and Mycobacterium avium Complex Lung Disease
por: Seto, Shintaro, et al.
Publicado: (2020)

Treatment Outcome of Combination Therapy Including Clarithromycin for Mycobacterium avium Complex Pulmonary Disease
por: Kim, Eun Young, et al.
Publicado: (2011)

Retrospective investigation of combination therapy with clarithromycin and levofloxacin for pulmonary Mycobacterium avium complex disease
por: Shimomura, Hitoshi, et al.
Publicado: (2015)

Azithromycin: A promising treatment option for Mycobacterium avium complex pulmonary disease in case of intolerance to clarithromycin
por: Oshima, Kengo, et al.
Publicado: (2021)

Pulmonary Mycobacterium avium Complex Infection Showing Extensive Consolidation
por: Yamazoe, Masami, et al.
Publicado: (2022)

Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease
por: Kadota, Tsukasa, et al.
Publicado: (2016)

813. Combination of N-Acetyl-Cysteine With Clarithromycin Against Mycobacterium avium Infection
por: Shiozawa, Ayako, et al.
Publicado: (2018)

Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes
por: Shimomura, Hitoshi, et al.
Publicado: (2015)

Treatment of Mycobacterium avium Complex Pulmonary Disease
por: Kwon, Yong-Soo, et al.
Publicado: (2019)

Retrospective evaluation of natural course in mild cases of Mycobacterium avium complex pulmonary disease
por: Kimizuka, Yoshifumi, et al.
Publicado: (2019)

Analysis of factors predicting the application of chemical pleurodesis for pneumothorax: An observational study
por: Shimoda, Masafumi, et al.
Publicado: (2022)

Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey
por: van Ingen, Jakko, et al.
Publicado: (2020)

Mycobacterium avium Complex Pleuritis with Elevated Anti-glycopeptidolipid-core IgA Antibody Levels in Pleural Effusion
por: Furuuchi, Koji, et al.
Publicado: (2019)

Combined administration of rifampicin, ethambutol, and clarithromycin for the treatment of tenosynovitis of the hand caused by Mycobacterium avium complex: Case series and literature review
por: Kaji, Yoshio, et al.
Publicado: (2021)

A Rapid Screening Assay for Clarithromycin-Resistant Mycobacterium avium Complex Using Melting Curve Analysis with Nonfluorescent Labeled Probes
por: Aoki, Akira, et al.
Publicado: (2023)

Multidrug Antibiotic Therapy for a Non-Human Immunodeficiency Virus-Infected Patient With Clarithromycin-Resistant Disseminated Mycobacterium avium Complex Disease
por: Kawamura, Ai, et al.
Publicado: (2021)

Long-Term Treatment Outcome of Progressive Mycobacterium avium Complex Pulmonary Disease
por: Fukushima, Kiyoharu, et al.
Publicado: (2020)

Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis
por: Yamashita, Yoshiro, et al.
Publicado: (2023)

A marmoset model for Mycobacterium avium complex pulmonary disease
por: Peters, Jay, et al.
Publicado: (2023)

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial
por: Winthrop, Kevin L., et al.
Publicado: (2021)

Inducible and Acquired Clarithromycin Resistance in the Mycobacterium abscessus Complex
por: Rubio, Marc, et al.
Publicado: (2015)

1899. Core Outcome Domains for Mycobacterium avium complex Pulmonary Disease Clinical Trials: Mycobacterium avium complex Core Outcomes Research (MACCOR)
por: Varley, Cara D, et al.
Publicado: (2023)

Pleuroparenchymal fibroelastosis in Mycobacterium avium complex pulmonary disease: clinical characteristics and prognostic impact
por: Yamamoto, Yuji, et al.
Publicado: (2021)

Consolidations in Nodular Bronchiectatic Mycobacterium Avium Complex Lung Disease: Mycobacterium Avium Complex or Other Infection?
por: Im, Soo Ah, et al.
Publicado: (2010)

Corrigendum: Antigen-specific cytokine profiles for pulmonary Mycobacterium avium complex disease stage diagnosis
por: Yamashita, Yoshiro, et al.
Publicado: (2023)

Mycobacterium shinjukuense infection successfully treated with clarithromycin, rifampicin, and ethambutol
por: Nakamura, Kayo, et al.
Publicado: (2023)

Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
por: Kim, Hyung-Jun, et al.
Publicado: (2019)

Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease
por: Wakabayashi, Hiroki, et al.
Publicado: (2019)

Exacerbating factors in elderly patients with Mycobacterium avium complex pulmonary disease
por: Kodaka, Norio, et al.
Publicado: (2021)

Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease
por: Chung, Eunki, et al.
Publicado: (2023)

Longitudinal changes in radiographic features of pulmonary Mycobacterium avium complex diseases
por: Watanabe, Chie, et al.
Publicado: (2023)

Simultaneous diagnosis of allergic bronchopulmonary aspergillosis and Mycobacterium avium complex lung disease
por: Takasaka, Naoki, et al.
Publicado: (2023)

The Contribution of Efflux Pumps in Mycobacterium abscessus Complex Resistance to Clarithromycin
por: Vianna, Júlia S., et al.
Publicado: (2019)

Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
por: Kumar, Kartik, et al.
Publicado: (2022)

Efficacy and safety of fluoroquinolone-containing regimens in treating pulmonary Mycobacterium avium complex disease: A propensity score analysis
por: Shuto, Hisayuki, et al.
Publicado: (2020)

Proposed Definitions for Epidemiologic and Clinical Studies of Mycobacterium avium Complex Pulmonary Disease
por: Plotinsky, Rachel N., et al.
Publicado: (2013)

1375. Laboratory Abnormalities Among Patients with Pulmonary Mycobacterium avium Complex Infections
por: Varley, Cara D, et al.
Publicado: (2019)

Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity
por: Kim, Bo-Guen, et al.
Publicado: (2022)

Efficacy of three sputum specimens for the diagnosis of Mycobacterium avium complex pulmonary disease
por: Urabe, Naohisa, et al.
Publicado: (2023)

Treatment outcomes and relapse in patients with Mycobacterium avium-intracellulare complex pulmonary disease
por: Chang, Chia-Ling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0t68d9vet4sn75ufofbjh0te30